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Abstract 
 The vertebrate heart develops from several progenitor lineages. After early-differentiating first heart field 
(FHF) progenitors form the linear heart tube, late-differentiating second heart field (SHF) progenitors extend 
atrium, ventricle, and form the inflow and outflow tracts (IFT/OFT). However, the position and migration of 
late-differentiating progenitors during heart formation remains unclear. Here, we tracked zebrafish heart 
development using transgenics based on the cardiopharyngeal transcription factor gene tbx1. Live-imaging 
uncovered a tbx1 reporter-expressing cell sheath that from anterior lateral plate mesoderm continuously 
disseminates towards the forming heart tube. High-speed imaging and optogenetic lineage tracing 
corroborated that the zebrafish ventricle forms through continuous addition from the undifferentiated 
progenitor sheath followed by late-phase accrual of the bulbus arteriosus (BA). FGF inhibition during sheath 
migration reduced ventricle size and abolished BA formation, refining the window of FGF action during OFT 
formation. Our findings consolidate previous end-point analyses and establish zebrafish ventricle formation 
as a continuous process. 
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Introduction 
 Vertebrate cardiomyocytes derive from an early versus a late differentiating progenitor pool that can be 
divided within the anterior lateral plate mesoderm (ALPM) into the FHF and SHF (Buckingham et al., 2005). 
After the early-differentiating FHF assembles the linear heart tube that in mammals forms the left ventricle 
and parts of the atria, the late-differentiating SHF contributes to the atria, right ventricle, and OFT (Kelly, 
2012; Kelly et al., 2001; Mjaatvedt et al., 2001; Tzahor and Evans, 2011). In mice, the SHF forms within 
medial and posterior epithelial-like field in the splanchnic ALPM on either side of the FHF-derived cardiac 
crescent and is detectable through expression of markers including Fgf10 and Isl1 (Cai et al., 2003; Francou 
et al., 2017; Kelly et al., 2001). Developmental defects in SHF contribution to the heart lead to a broad 
variety of congenital heart defects affecting the arterial pole(Srivastava and Olson, 2000). The original 
purpose of a second late-forming wave of myocardium remains unknown. An emerging concept places the 
SHF in close developmental and evolutionary lineage relationship with pharyngeal and head muscle 
progenitors: in this context, the cardiopharyngeal field (CPF) is defined across chordate species as a 
domain within the splanchnic or pharyngeal ALPM harboring SHF and branchiomeric progenitor cells (Diogo 
et al., 2015). Consequently, a key aspect of SHF is its cardiac specification coordinated with head muscle 
differentiation (Wang et al., 2017). 
 
 The basic mechanisms of vertebrate heart formation are evolutionarily conserved. Typical for teleosts, the 
zebrafish heart consists of two chambers, an atrium and a ventricle (Figure 1A). At the arterial pole, the 
myocardium transitions into laminin-rich myocardium referred to as conus arteriosus (CA) followed by the 
elastic bulbus arteriosus (BA) that functions as smooth muscle-based pressure capacitator similar to the 
mammalian aortic arch (Grimes and Kirby, 2009; Moriyama et al., 2016); the CA together with the BA are 
commonly, but not consistently, defined as OFT (Grimes and Kirby, 2009; Grimes et al., 2006) (Figure 1A). 
Cardiac progenitors become detectable in the zebrafish ALPM by bilateral expression of several conserved 
cardiac transcription factors, including nkx2.5, hand2, and gata4/5 (Chen and Fishman, 1996; Reiter et al., 
1999; Schoenebeck et al., 2007; Yelon et al., 2000). By 14-18 hours post-fertilization (hpf), bilateral 
progenitors condense at the midline as cardiac disc that forms the cardiac cone; the subsequently emerging 
linear heart tube consists of endocardium and surrounding early differentiating cardiomyocytes referred to 
as FHF myocardium, discernible at 16-18 hpf by differentiation markers including myl7 (Bakkers, 2011; 
Fishman and Chien, 1997; Stainier et al., 1993). Myocardial expression of drl-based transgenes selectively 
marks FHF-derived cardiomyocytes from late somitogenesis (Mosimann et al., 2015). Starting from 26 hpf, 
akin to the mammalian heart, a late-differentiating wave of prospective cardiomyocytes and smooth muscle 
cells extends the venous IFT and arterial OFT of the beating zebrafish heart, referred to as SHF lineage 
(Hami et al., 2011; Lazic and Scott, 2011; Zhou et al., 2011) (Figure 1A). The zebrafish heart therefore 
recapitulates key processes of multi-chambered heart formation (Bakkers, 2011). 
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 Lineage tracing, several molecular markers including ltbp3, isl1, and mef2c, or the maturation speed of 
fluorescent reporters have been used to describe late differentiating SHF-like myocardium (Hami et al., 
2011; Lazic and Scott, 2011; de Pater et al., 2009; Witzel et al., 2017, 2012; Zhou et al., 2011). 
Nonetheless, the lineage separation and developmental connection between the ventricular myocardium 
and OFT structures remains vaguely defined. Further, the position of SHF-assigned cells during formation of 
the linear heart tube has remained uncertain. Genetic lineage tracing has shown that both distal ventricle 
and OFT derive from nkx2.5- and ltbp3-reporter-expressing cells (Guner-Ataman et al., 2013; Zhou et al., 
2011). nkx2.5:Kaede-based lineage tracking has indicated that most of the ventricular myocardium is 
already condensed at the cardiac disc, but if all these cells then migrate with the emerging linear heart tube 
or stay behind has remained unresolved (Paffett-Lugassy et al., 2017). nkx2.5:Kaede further marks a 
seemingly distinct group of cells posterior and outside of the forming heart tube that also contributes 
myocardial progenitors to the distal ventricle and OFT (Zeng and Yelon, 2014); how these cells connect to 
the other ventricular progenitors remains to be uncovered. Position-based cell labeling experiments have 
mapped BA origins to the medio-central region of the heart-forming ALPM that corresponds to the 
expression domain of nkx2.5 and gata4 (Hami et al., 2011), with the proximal-most part of the BA arising 
from nkx2.5 reporter-expressing pharyngeal arch 2 mesoderm (Paffett-Lugassy et al., 2017). Altogether, 
these analyses support a model of addition of the majority of late-differentiating myocardium to the ventricle 
and BA formation after establishment of the linear heart tube. 
 
 The T-box transcription factor Tbx1 is expressed within the CPF of various chordates and directs cardiac 
development by maintaining proliferation and suppressing differentiation of SHF cardiac progenitor cells 
(Chen et al., 2009; Diogo et al., 2015; Onimaru et al., 2011; Scambler, 2010). Impaired TBX1 in humans 
results in DiGeorge Syndrome (Scambler, 2010) with variable cardiac defects including Tetralogy of Fallot, 
OFT defects, and an interrupted aortic arch, defects recapitulated by Tbx1-mutant mice (Jerome and 
Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001). The zebrafish tbx1 mutant van gogh (vgo) 
displays among other phenotypes defects in the pharyngeal arches and a smaller BA, underlining the 
conserved function of Tbx1 in CPF control (Choudhry et al., 2013; Piotrowski et al., 2003). The 12.8 
kilobases (kb) upstream of the murine Tbx1 gene as transgenic reporter principally recapitulate endogenous 
expression through separable Forkhead factor-binding enhancers that drive pharyngeal/anterior endoderm 
versus mesoderm expression, including activity in the OFT (Hu et al., 2004; Maeda et al., 2006; Yamagishi 
et al., 2003). While these enhancers are sufficient in transgenic reporters, endogenous Tbx1 expression is 
redundantly coordinated with additional activating and suppressing elements in the vicinity of the locus 
(Zhang and Baldini, 2010). 
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 Here, we have isolated upstream cis-regulatory elements from the zebrafish tbx1 locus to visualize the 
dynamics of ventricle and OFT formation. Combining selective plane illumination microscopy (SPIM) 
imaging with genetic and optogenetic lineage tracing, we captured the formation of the linear heart tube with 
concomitant migration of an undifferentiated sheath of tbx1 reporter-expressing cells that are continuously 
added to, and gradually differentiate at, the arterial pole of the heart. Meanwhile, BA progenitors reside in 
the tbx1 reporter-positive pharyngeal ALPM and migrate later towards the late-differentiating distal pole of 
the ventricle to become smooth muscle. Combining chemical and genetic perturbations, we found a distinct 
temporal requirement for FGF signaling in controlling ventricle and BA size versus BA specification. In 
contrast to models that postulate a distant cellular origin and stepwise addition of SHF cells, our findings 
establish that incorporation of the zebrafish ventricle, and OFT structures into the linear heart tube is a 
continuous process with distinct phases of FGF activity during CPF differentiation. 
 
 
Results 
cis-regulatory elements of the zebrafish tbx1 locus are active in cardiac progenitors 
 In our ongoing efforts to isolate cis-regulatory elements active within the lateral plate mesoderm (LPM) to 
observe cardiovascular cell fate partitioning, we generated zebrafish tbx1 reporter transgenics based on the 
high ranking of tbx1 expression in transcriptome analysis of zebrafish LPM (within top-20 enriched genes) 
(Mosimann et al., 2015). Transgenic reporters in mice have established 5’ core regulatory elements 
sufficient for recapitulating Tbx1 expression (Yamagishi et al., 2003). Consistently, we observed specific 
EGFP reporter activity driven by the 3.2 kb upstream region of zebrafish tbx1 in embryos carrying transgenic 
insertions of Tg(-3.2tbx1:EGFP)zh703, with minimal variability between six individual transgenic lines (Figure 
1B, Supplementary Figure 1, Supplementary Table 1). 
 
 In late epiboly, tbx1:EGFP akin to endogenous tbx1 expression broadly labels a dorsal/anterior domain 
(Figure 1C, Supplementary Figure 1). During somitogenesis, tbx1:EGFP expression is detectable in anterior 
bilateral domains (Figure 1D,E) and at 36 hpf in the pharyngeal arches and in the heart (Figure 1F). While 
we do not detect significant endogenous tbx1 mRNA expression in the heart consistent with previous 
reports (Nevis et al., 2013), we readily observed tbx1:EGFP expression in cardiac precursors, indicating 
distinct dynamics of our reporter compared to endogenous tbx1 akin to mouse Tbx1 reporters 
(Supplementary Figure 1) (Hu et al., 2004; Maeda et al., 2006; Yamagishi et al., 2003). To resolve tbx1 
reporter expression in relation to the drl-labelled LPM (Mosimann et al., 2015), we performed in toto 
panoramic SPIM imaging (Schmid et al., 2013) on tbx1:EGFP;drl:mCherry transgenic embryos from 
gastrulation (70% epiboly) to mid-somitogenesis (15 hpf) (Supplementary Video 1). At late epiboly to tailbud 
stages, when the LPM condenses around the embryo margin, we detected overlapping tbx1:EGFP 
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expression in drl:mCherry-expressing LPM cells, medial within the ALPM and lateral-most within the tbx1 
reporter-expressing domain (Figure 1G,H). These cells condensed further at the margin of the tbx1:EGFP-
expressing domain throughout early somitogenesis (Figure 1I,J). Thus, a sub-population of the tbx1 
reporter-expressing cells represent ALPM, while the broad medial field of tbx1 reporter-positive cells 
potentially represent endoderm precursors, as we observe labeling of endodermal derivatives in i) 3 dpf 
tbx1:EGFP-expressing embryos, as well as ii) in CreERT2/lox-mediated lineage tracing of (Tg(-
3.2tbx1:creERT2)zh703 transgenics (Supplementary Figure 2). Moreover, cranial cartilage is labelled by tbx1 
reporter expression and with tbx1:creERT2-mediated lineage tracing, suggesting additional tbx1 reporter 
expression in neural crest lineages (Supplementary Figure 2). Taken together, transgenic zebrafish reporter 
expression based on the upstream 3.2 kb tbx1 cis-regulatory region approximates key aspects of reported 
Tbx1 activity (Chen et al., 2009; Diogo et al., 2015; Garg et al., 2001) and visualizes a dynamic anterior 
endoderm and mesoderm domain that includes ALPM. 
 
ALPM-derived tbx1 reporter-expressing cells contribute to both venous and arterial poles of the 
heart 
 To resolve cardiac tbx1:EGFP expression, we analyzed tbx1:EGFP transgenics co-stained for the 
differentiated cardiomyocyte-expressed Myosin Heavy Chain 1E (MYH1E, MHC) (Figure 2A). At 26 hpf, 
when the differentiating cardiomyocytes in the linear heart tube represent FHF derivatives (Mosimann et al., 
2015; de Pater et al., 2009), we detected tbx1 reporter expression in most of the differentiated ventricular 
cardiomyocytes and additionally in two MHC-negative domains at the IFT and OFT (Figure 2A). At 26 hpf, 
we detected tbx1:EGFP;Isl1 double-positive cells at the IFT of the linear heart tube (Figure 2B,C), 
consistent with inferred SHF identity of IFT cells (Caputo et al., 2015; de Pater et al., 2009; Witzel et al., 
2017). 
 
 To corroborate which cardiac lineages form from tbx1 reporter-expressing cells, we performed genetic 
lineage tracing with tbx1:creERT2 and hsp70l:Switch (Tg(-1.5hsp70l:loxP-STOP-loxP-
EGFP,cryaa:Venus)zh701 (Figure 2D). 4-OHT induction of CreERT2 at shield stage to 90% epiboly (6-9 hpf) 
labelled ventricular cardiomyocytes, including the distal ventricle and OFT region, scattered atrial cells 
around the IFT, and the Diaminorhodamine-4M AM (DAR-4M)-reactive smooth muscle cells in the BA 
(Grimes et al., 2006) (Figure 2E, Supplementary Figure 3). These cardiac descendants of tbx1 reporter-
expressing cells likely derive from ALPM: pan-LPM lineage tracing using drl:creERT2 from 90% epiboly 
broadly marks atrial and ventricular myocardium plus the DAR-4M-stained BA (Figure 2F, Supplementary 
Figure 3), in line with previous LPM labeling by drl:creERT2 (Felker et al., 2016; Henninger et al., 2016; 
Mosimann et al., 2015) and selective ALPM tracing of OFT structures (Guner-Ataman et al., 2013; Paffett-
Lugassy et al., 2017). While drl-mediated ALPM lineage tracing labeled the endocardium, cranial vessels 
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(Figure 2F, Supplementary Figure 3), and several head muscle groups (Supplementary Figure 3), tbx1 
reporter expression and lineage tracing labeled the same structures without endocardium, but additionally 
also craniofacial cartilage and endoderm derivatives, in line with Tbx1 as CPF marker (Diogo et al., 2015) 
(Figure 2A, Figures S2, S3). These results indicate that the tbx1 reporter expression domain entails ALPM-
derived cells that contribute to cardiac lineages including IFT and OFT structures (Figure 2E-G). 
 
tbx1 reporter-expressing progenitors contribute to and migrate together with the linear heart tube 
 By end point analysis in zebrafish, different positions and migration dynamics have been assigned to IFT-, 
ventricle-, and OFT-contributing undifferentiated SHF progenitors, including delayed migration from 
pharyngeal ALPM (Hami et al., 2011; Lazic and Scott, 2011), condensation with the forming cardiac disc 
(Paffett-Lugassy et al., 2017), and localization posterior to the forming cardiac cone (Zeng and Yelon, 2014). 
To visualize the cardiac tbx1 reporter-expressing cells, we SPIM-imaged tbx1:EGFP;drl:mCherry embryos 
from 16 hpf (14 ss) to 22-24 hpf to capture all stages of heart field migration up to the onset of heart beat 
(Supplementary Video 2). Of note, at these stages drl:mCherry expression in the heart field gradually 
confines from earlier pan-LPM expression to restricted expression in FHF-derived lineages, and robust 
expression in the endocardium (Mosimann et al., 2015). At 14 ss, the drl:mCherry-expressing heart field is 
arranged as a bilateral LPM domain as is the nearly overlapping tbx1 reporter-expressing field before 
condensing at the midline (Figure 3A,B). From approximately 16 ss onwards, while midline-centered 
migration and formation of the drl:mCherry-positive cardiac disc completed, tbx1:EGFP-positive cells 
contributed to the cardiac disc (Figure 3B) and further disseminated from the bilateral tbx1 reporter domain 
to migrate medially along drl-positive endothelial progenitors (Figure 3C). By 22 hpf, tbx1 reporter-positive 
cells formed a sheath of cells at the prospective arterial pole of the both tbx1 and drl reporter-expressing 
linear heart tube (Figure 3D); 3D segmentation confirmed that in its entirety, the tbx1 reporter-positive cell 
population surrounded the growing endocardium like a sleeve trailing outwards to the still bilateral 
progenitors (Figure 3E,F, Supplementary Video 3). These observations suggest co-migration of tbx1 
reporter-expressing cells as part of the forming and jogging linear heart tube and continuous with the 
prospective arterial pole (Figure 3E,F). 
 
The late differentiating tbx1 domain is continuous with the early forming myocardium 
 To understand the formation of the arterial pole of the heart tube in greater detail, we imaged 
tbx1:EGFP;myl7:DsRed2 double-transgenic embryos from 18-30 hpf (Supplementary Video 4, 
Supplementary Figure 4). The slow folding of DsRed2 during this time frame discriminates between the 
early differentiated, early DsRed2-positive (FHF-assigned) and the later differentiating, DsRed2-negative 
(SHF-assigned) myl7-expressing cardiomyocytes (de Pater et al., 2009; Witzel et al., 2012). 
Correspondingly, we detected myl7:DsRed2 expression in the migrating and differentiating heart tube from 
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24 hpf onwards (Supplementary Figure 4). We observed tbx1 reporter-expressing cells at the arterial pole of 
the heart tube i) that based on absence of myl7:DsRed2 expression throughout 24-30 hpf correspond to the 
later differentiating SHF myocardium, and ii) that were connected to, and migrated together with, the myl7-
positive myocardium (Supplementary Figure 4). 
 
 To overcome the complications of live tracking associated with the onset of the heart beat at 24 hpf with 
continued ventral and rostral heart tube migration (Guner-Ataman et al., 2013; Hami et al., 2011; Lazic and 
Scott, 2011; Mosimann et al., 2015), we performed SPIM-based high-speed imaging and reconstruction of 
the beating zebrafish heart from 28 to 52 hpf (Mickoleit et al., 2014). We imaged tbx1:EGFP;myl7:DsRed2 
embryos from a lateral view (right side) to optimally resolve the migrating and looping ventricle (Figure 4A-C, 
Supplementary Video 5). Linking to our previous time course, we observed the tbx1:EGFP-
positive/myl7:DsRed2-negative cells connected to the differentiating, myl7:DsRed2-fluorescent myocardium 
at 28 hpf (Figure 4A); displacement of these cells due to the beating differentiated myocardium supports 
their continuous incorporation into the heart tube (Supplementary Video 6). Throughout ventricle looping, 
the initially solely tbx1 reporter-positive cells became re-arranged within the ventricle, intercalated with 
myl7:DsRed2-expressing differentiated cardiomyocytes, and gradually turned on myl7:DsRed2 expression 
(Figure 4B,C), in agreement with the previously described late SHF-derived myocardial differentiation (Lazic 
and Scott, 2011; de Pater et al., 2009; Zhou et al., 2011). Imaging of still hearts showed that all ventricle-
incorporated tbx1:EGFP-expressing cells were differentiated and expressed myl7:DsRed2 by 54 hpf (Figure 
4D). In addition, tbx1 reporter-expressing undifferentiated cells that gradually upregulated myl7 expression 
also appeared at the IFT (Figure 4A-C). 
 
 In our high-speed time-lapse, we noted that from time point 35 (approx. 39 hpf) a new cluster of tbx1-
reporter-expressing cells appeared at the OFT that expanded throughout the rest of recorded cardiac 
development, but never crossed into the ventricle (Figure 4B,C, Supplementary Video 5); we hypothesized 
that these cells are BA progenitors. Indeed, we detected tbx1:EGFP expression at 3-4 dpf in the 
differentiated BA smooth muscle (Figure 4E), consistent with our genetic lineage tracing (Figure 2E). We 
corroborated our live imaging data by examining tbx1:EGFP reporter expression in dissected hearts of 
transgenic embryos (Figure 4F-J); we observed tbx1:EGFP-positive cells at the distal ventricle of 26 hpf 
hearts that did not express MHC at this time (Figure 4F). At 54 hpf, we detected differentiated 
cardiomyocytes expressing tbx1:EGFP as well as potential BA precursors at the OFT that did not express 
MHC (Figure 4G,H). At 3 dpf, the differentiated smooth muscle but not the endothelium of the BA was 
clearly marked by tbx1:EGFP expression (Figure 4I,J, Supplementary Figure 4).  
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 Altogether, our live imaging data confirmed by analysis in isolated hearts i) provide real-time observation of 
late-differentiating ventricle myocardium, and ii) confirm that tbx1 reporter-positive cells that co-migrate with 
the early differentiating cardiac cone subsequently differentiate to ventricular cardiomyocytes, including the 
late-differentiating myocardial pool at the arterial pole (de Pater et al., 2009; Zhou et al., 2011). Moreover, 
we detect a second phase of tbx1 reporter-expressing cells adding to the heart at later stages and 
potentially making the smooth muscle of the BA.  
 
The tbx1 reporter-expressing sheath forms the majority of the ventricular myocardium 
 While corresponding to our tbx1:creERT2 lineage tracing (Figure 2E), active EGFP reporter expression is 
not strict evidence for lineage association. To confirm the lineage contribution of the tbx1 reporter-
expressing cardiac sheath to the ventricular myocardium and OFT, we performed optogenetic lineage 
tracing using the transgenic line Tg(-3.2tbx1:H2B-Dendra2)zh704 (subsequently as tbx1:Dendra2); in 
tbx1:Dendra2, a nuclear histone 2B-linked Dendra2 fluorophore is constitutively green-fluorescent and turns 
irreversibly red upon photoconversion (Gurskaya et al., 2006). We photoconverted tbx1:Dendra2-positive 
cells of the cardiac cone and trailing sheath at 22 hpf (Figure 5A) and detected Dendra2-red positive 
cardiomyocytes at 3.5 dpf throughout the ventricle, including the SHF-assigned distal portion and the inner 
curvature (n=10/11, N=4; Figure 5B, Supplementary Figure 5). These observations suggest that the 
tbx1:Dendra2-expressing sheath contributes to FHF- and SHF-linked ventricular myocytes. When 
converting tbx1:Dendra2-expressing cells at the base of and posterior to the cone in the area previously 
assigned to harbor additional myocardial SHF precursors (Zeng and Yelon, 2014) (Figure 5C), we could 
detect a few distal cardiomyocytes only on the dorsal side of the ventricle labelled by Dendra2-red (n=3/3, 
N=1; Figure 5D). We identified the majority of the ventricle to be derived from tbx1:Dendra2-expressing cells 
present already in the cone, and only a small fraction of cardiomyocytes accrued later. The SHF contribution 
was previously reported to comprise 40-50% of the ventricular myocardium (Lazic and Scott, 2011; 
Mosimann et al., 2015; Zhou et al., 2011); thus, our data suggests that the majority of late-differentiating 
cardiomyocyte progenitors enter the heart trailing the early differentiating ventricular progenitors by 22 hpf 
as part of a continuous tbx1 reporter-expressing cell sheath. 
 
 In contrast to ventricular cardiomyocytes, we could not detect any Dendra2-red cells in the BA after 
photoconversion at the trailing end of the cardiac cone (n=0/11, N=4; Figure 5A,B, Supplementary Figure 5). 
In contrast, consistent with earlier position-based lineage tracing (Hami et al., 2011; Paffett-Lugassy et al., 
2017), we detected Dendra2-red-positive cells in the BA when converting the pharyngeal ALPM lateral to 
the forming cardiac cone (n=15/15, N=4; Figure 5E,F). The right and left sides of the BA were exclusively 
formed from the corresponding side with no discernible cross-over (n=3/3 left side and n=3/3 right side, total 
n=6/6, N=3; Figure 5E,F, Supplementary Figure 6). Moreover, different regions of the pharyngeal LPM 
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contributed to different parts of the BA on a proximal to distal axis and additionally labeled different 
craniofacial structures (n=3/3 proximal part, n=3/3 medial part, n=3/3 distal part, N=2; Figure 5E,F; 
Supplementary Figure 6). Taken together, our data document that the majority of, if not all, ventricular 
cardiomyocytes stem from a tbx1 reporter-expressing progenitor sheath that participates in cardiac ALPM 
fusion, contributes to the linear heart tube, and trails the prospective arterial pole. In contrast, SHF-assigned 
BA precursors within the pharyngeal ALPM add to the heart at a subsequent stage as more distantly trailing 
cells, as has been reported for OFT lineages in mammals (Kelly et al., 2001; Mjaatvedt et al., 2001). 
 
FGF signaling selectively controls tbx1+ progenitor addition to the zebrafish heart 
  FGF signaling influences cardiac patterning including SHF development in various chordates (Rochais et 
al., 2009). Correspondingly, zebrafish embryos mutant for fgf8a (acerebellar, ace) or upon fgf8a morpholino 
knockdown form a severely hypoplastic ventricle with comparably normal atrium (de Pater et al., 2009; 
Reifers et al., 2000). Moreover, chemical perturbations using the pan-FGF signaling inhibitor SU5402 
(Marques et al., 2008; Mohammadi et al., 1997; Simoes et al., 2011) from earliest phases of heart formation 
result in reduced late-differentiating myocardium and loss of SHF marker expression at the arterial pole 
(Lazic and Scott, 2011; de Pater et al., 2009). 
 
 To determine the temporal requirement for FGF signaling on the different phases of cardiac contribution 
from the tbx1 reporter-expressing ALPM field, we first revisited the fgf8a phenotype using the verified fgf8a 
translation-blocking morpholino MO3-fgf8aATG (Scholpp and Brand, 2001). We measured ventricle and BA 
size upon fgf8a perturbation in isolated hearts: fgf8a morphants still faithfully expressed tbx1:EGFP and 
formed a BA (Figure 6A-D), yet both ventricle and BA were significantly smaller (Figure 6E,F) consistent 
with previous reports (Marques et al., 2008; de Pater et al., 2009; Reifers et al., 2000). The impact on 
ventricle and BA size is unlikely from a strong disruption of FHF or SHF territories, as at 54 hpf expression 
of drl:EGFP that demarcates FHF-derived myocardium appeared insignificantly affected upon fgf8a 
perturbation (Figure 6G-I). 
 
 To resolve the temporal influence of FGF signaling, we treated tbx1:EGFP embryos with SU5402 when 
tbx1 reporter-expressing ventricular progenitors migrate to contribute to the forming heart tube. When we 
initiated SU5402 treatment before medial migration at 14 ss and perturbed FGF signaling throughout sheath 
migration (pulse treatment from 14 ss to 22 hpf), 5 µM SU5402-treated embryos showed diminished but still 
ongoing migration of the tbx1:EGFP-expressing sheath by 26 hpf (Figure 7A,B). In line with previous 
findings (Marques et al., 2008), at 3 days post-fertilization (dpf) the ventricle of these embryos appeared 
smaller, but nonetheless contained tbx1:EGFP-expressing cardiomyocytes (Figure 7C,D). We observed 
similar results when continuously perturbing FGF signaling with lower dose of 2 µM SU5402 from 14 ss 
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onwards till imaging at 3 dpf (Figure 7E). These results demonstrate an impact of FGF signaling during tbx1 
reporter-expressing sheath migration, consistent with an early role of FGF signaling in ventricle formation. 
 
 In contrast to the mere reduction in ventricle size upon FGF inhibition, we observed a more striking and 
concentration-dependent effect on BA addition (Figure 7C-H). Even though BA addition takes place after 
primary heart tube formation at 24 hpf, BA formation was completely absent in a substantial number of 
embryos pulse-treated between 14 ss to 22 hpf with 5 µM SU5402 when assessed at 3 dpf as apparent by 
tbx1:EGFP or DAR-4M labelling (Figure 7D,F,H; Supplementary Figure 7; no BA in n=29/43 by tbx1 reporter 
and n=5/15 by DAR-4M, total n=34/58, N=4; DMSO-treated controls: normal BA in n=58/58 by tbx1 reporter 
and n=10/10 by DAR-4M, total n=68/68, N=4). While pulsing SU5402 treatment between 14 ss to 22 hpf 
with 2 µM SU5402 led to detectable BA differentiation (Figure 7F; present BA in n=15/15 by tbx1 reporter 
and n=15/15 by DAR-4M, total n=30/30, N=2), continuously treated embryos from 14 ss onwards with 2 µM 
SU5402 lacked BA (Figure 7E,F; no BA development in n=4/6 by tbx1 reporter and n=21/26 by DAR-4M, 
total n=25/32, N=3). In line, 5 µM SU5402 pulse-treatment from 24 hpf to 28 hpf or 34 hpf merely caused 
formation of smaller BA and never caused loss of the differentiated BA (pulse 24-28 hpf: n=20/20 by tbx1 
reporter, pulse 24-34 hpf: n=20/20 by DAR-4M; total n=40/40, N=3) (Figure 7I, Supplementary Figure 7). 
 
 Taken together, our data determine a temporally defined requirement for FGF signaling during formation 
and migration of the ventricle progenitor sheath. Further, our findings support a model in which differential 
levels and timing of FGF control the continuous addition of ventricle and BA progenitors to the heart tube, 
with a sensitive window for BA determination before its progenitors leave the pharyngeal ALPM. 
 
 
Discussion 
 The concept of distinct phases of differentiating cell types contributing to individual parts of the multi-
chambered heart is deeply rooted in chordate evolution. Here, we visualized the formation of the zebrafish 
ventricle and OFT structures from a continuously differentiating progenitor sheath that emerges from tbx1 
reporter-expressing ALPM and surrounds the emerging endocardium. Our data connects, is consistent with, 
and extends previous end-point analyses of early- versus late-differentiating myocardium and the formation 
of OFT structures including the BA. We further reveal a temporal influence and sensitivity of FGF signaling 
on ventricle myocardium versus BA smooth muscle formation in zebrafish. Our work emphasizes cardiac 
development as part of a tbx1-expressing cardiopharyngeal progenitor field within the bilateral ALPM that is 
already significantly pre-patterned before its medial migration forms the heart. 
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 Reporter expression and lineage tracing (Figures 1, 2, Figures S2, S3) established the isolated zebrafish 
tbx1 cis-regulatory region as a putative marker of the CPF that resides within the ALPM aside cranial 
endoderm and neural crest lineages. We have combined different strategies to demonstrate that our tbx1 
regulatory elements visualize early as well as late-differentiating cardiac lineages. When live-imaging 
tbx1:EGFP-expressing embryos from stages before heart field migration (14 ss) up to cardiac looping 
stages (54 hpf), we robustly detected tbx1 reporter-expressing cells at the arterial pole of the ventricle that 
were connected to the differentiated myl7-expressing myocardium and started moving in sync with 
heartbeat of the primitive heart tube (Figures 3,4, Supplementary Videos 2-6); this observation suggests that 
undifferentiated tbx1 reporter-expressing cells are already physically linked to beating cardiomyocytes. 
These tbx1:EGFP-expressing progenitors then gradually upregulated myl7 expression, confirming their 
identity as cardiomyocyte progenitors equivalent to late-differentiating SHF-liked cells (Figure 4A-C, 
Supplementary Video 5) (de Pater et al., 2009; Witzel et al., 2012). Independent of continued tbx1 reporter 
activity, genetic and optogenetic lineage tracking supports the notion that most, and likely all, FHF- and 
SHF-assigned ventricular cardiomyocytes are contained within the tbx1 reporter-expressing sheath that 
contributes to the cardiac cone and trails into the bilateral ALPM (Figure 5A-D, Supplementary Figure 5). Of 
note, the SHF in mouse has been characterized as epithelial sheet that undergoes epithelial-to-
mesenchymal transitions and tension changes during its addition to the heart tube (Francou et al., 2017). 
Our observations hint at similar dynamics of SHF cells in teleosts. 
 
 The observed addition of ventricle progenitors as continuous process connects previously observed key 
time points of SHF-assigned, late-differentiating myocardium addition to the zebrafish heart tube (Lazic and 
Scott, 2011; Mosimann et al., 2015; Paffett-Lugassy et al., 2017; Zhou et al., 2011). Nonetheless, the 
position of SHF-assigned cells during heart tube assembly had previously remained ambiguous. 
nkx2.5:Kaede reporter-based optogenetic lineage tracking showed that most if not all ventricular 
myocardium is already condensed at the cardiac disc, but if these cells then migrate with the emerging 
primitive heart tube or stay behind had remained unresolved (Paffett-Lugassy et al., 2017). A distinct group 
of nkx2.5:Kaede-expressing cells were found more posterior, seemingly outside of the forming heart tube, 
and shown to form a small portion of the distal ventricle and OFT myocardium (Zeng and Yelon, 2014). Our 
tbx1 reporter transgenics now consolidate these data points as parts of the continuous cell sheath forming 
the ventricle.  
 
 On the contrary, smooth muscle cells in the BA were contributed from the still bilateral pharyngeal ALPM 
lateral and posterior to the developing heart tube (Figure 5E,F, Supplementary Figure 6), a development 
that also appears in our live imaging data (from approximately 39 hpf, time point 35 in Figure 4B,C, 
Supplementary Video 5). Inferred by reporter expression and not strictly lineage data, our analysis of 
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dissected hearts at 54 hpf (Figure 4F-J) confirms the existence of a tbx1 reporter-expressing, non-
myocardial cell population at the OFT pole, the position where we later find the differentiated BA (Figure 
4E,J). Addition of BA precursors to the distal ventricle has been reported as early as 48 hpf by 4,5-
diaminofluorescein diacetate (DAF-2DA) staining that senses nitric oxide accumulating in the BA and likely 
requires functional maturation of smooth muscle (Grimes et al., 2006). A concise working definition 
(proposed in Figure 1A) to distinguish between distal ventricle myocardium, collagenous OFT myocardium 
of the CA, and BA could further consolidate the various reports of distinct waves of SHF-assigned cells to 
the heart tube that have been referred to by mixed nomenclature (Grimes and Kirby, 2009). Our data 
suggest a continuous addition of ventricle myocardium and a subsequent addition of smooth muscle 
progenitors as distinct phases of a continuous process. 
 
 FGF signaling has been previously reported to govern progenitor addition to the arterial pole of the 
zebrafish heart (Lazic and Scott, 2011; de Pater et al., 2009). Consistent with these previous findings, we 
observed a diminished ventricle upon pan-FGF signaling perturbation during tbx1 reporter-expressing 
sheath formation (Figure 7C-E). We further detected absent BA formation when initiating chemical FGF 
signaling block already before cardiac cone formation (Figure 7F-I). In contrast, knockdown of the key 
cardiac FGF ligand gene fgf8a merely caused a smaller ventricle and BA (Figure 6A-F), akin to pulsed 
exposure to a low dose of SU5402 during ventricle formation and BA accrual at 14 ss-22 hpf (Figure 7F). To 
our knowledge, the drastic temporal influence of FGF signaling on BA formation has not been previously 
described in zebrafish. Fgf8 depletion in mouse results in aberrant OFT development including severe aortic 
arch defects, a structure probably most comparable to the teleost BA (Abu-Issa et al., 2002; Frank et al., 
2002). We only observed complete failure of BA formation when all FGF signaling was blocked before 
cardiac cone stages, but not when perturbed later during heart tube stages or by sub-penetrant doses of 
SU5402 (Figure 7F-I).  
  
 Our data is consistent with two effects of FGF signaling on zebrafish heart development after initial cardiac 
specification: first, FGF signaling regulates ventricular myocardium formation during medial migration of 
ventricular progenitors and cardiac cone formation; second, FGF signaling controls smooth muscle 
precursors residing in the pharyngeal ALPM prior to their OFT addition. Work on chick SHF explants has 
established that loss of FGF signaling blocks proliferation and causes myocardial differentiation, while 
elevating FGF signaling drives SHF cells into smooth muscle fates (Hutson et al., 2010). In Ciona, an FGF-
driven regulatory circuit controls key cardiopharyngeal transcription factors including Tbx1/10, and regulates 
cell cycle dynamics to permit differentiation of individual cardiac lineages (Davidson et al., 2006; Razy-
Krajka et al., 2017; Wang et al., 2017). These results are in line with our temporal and dose requirement for 
FGF during zebrafish ventricle and OFT formation (Figure 7), suggesting that BA progenitors already have 
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an assigned fate during heart cone formation. Regulation of OFT progenitors while they reside in the 
pharyngeal LPM points towards an FGF activity gradient mediated by adjacent structures. 
 
 Of note, we also detected a late differentiating cardiomyocyte population at the venous pole, the IFT, of the 
heart (Figure 4A-C), in accordance with previous findings of late IFT myocardial differentiation (de Pater et 
al., 2009). tbx1 reporter-expressing cells at the IFT concomitantly expressed Isl1, confirming their SHF 
signature (Figure 2B,C). We did not detect any Isl1 expression at the OFT, in accordance with other studies 
in zebrafish implicating Isl1 only in IFT development (Caputo et al., 2015; de Pater et al., 2009; Witzel et al., 
2017). While we here focused on the development of the arterial pole, these observations warrant 
application of our tbx1 reporter transgenics for the elucidation of zebrafish IFT formation.  
 
 Altogether, our data provide new insights into the dynamics of ventricle and OFT formation and integrate 
their mechanistic separation as distinct phases of a continuous developmental process in zebrafish. 
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Figure Legends: 
 
Figure 1: tbx1 reporter expression and lineage contribution in the cardiopharyngeal and ALPM field.  
(A) Confocal Z-projection and schematic representation of a 72 hpf zebrafish heart with two chambers, 
the ventricle (V) and atrium (A) separated by a valve at the atrioventricular canal (AVC). The isolated 
heart is stained for MHC marking the myocardium (magenta) and a-PKC marking all cells (green). The 
FHF-assigned myocardium contains the proximal ventricle (pV) and the majority of the atrium (A), SHF-
assigned myocardium forms the distal ventricle (dV) and outflow tract (OFT), magenta and green in the 
schematic, respectively. The OFT includes the conus arteriosus (CA), comprising the myocardial 
connection of the ventricle to the bulbus arteriosus (BA), and the smooth muscular BA itself. The lineage 
contributions to the sinus venosus (SV)/inflow tract (IFT) and developmental timing of IFT valve 
formation remain unresolved. IC, inner curvature; OC, outer curvature. (B) Genomic locus of the 
zebrafish tbx1 gene; red arrow indicates 3.2 kb cis-regulatory region amplified to drive reporter 
transgenics. (C) tbx1:EGFP reporter transgene expression in a dorsal/anterior field during gastrulation 
(90% epiboly, dorsal/anterior to the left). (D,E) tbx1:EGFP at 14 ss; dorsal (D) and lateral views (E) of the 
prospective cardiopharyngeal field (CPF, arrowheads). (F) Lateral view of a 36 hpf tbx1:EGFP embryo 
with EGFP expression in the CPF-derived pharyngeal arches (pa3-7) and heart (asterisk). EGFP 
expression also marks the prechordal mesoderm-derived hatching gland (hg), insets depict bright-field. 
(G-J) Mercator projection of representative stages from panoramic SPIM-imaged tbx1:EGFP;drl:mCherry 
double-positive transgenic embryos; dorsal views. tbx1:EGFP expression is confined to the anterior of 
the embryo, with no EGFP signal in the posterior LPM (PLPM). Expression in the notochord (nc) and 
hatching gland (hg) are likely related to early prechordal plate activity of the reporter. Note double -
positive cells at the outermost domain of the tbx1:EGFP-positive anterior cell population (arrowheads 
and bracket). Scale bars 100 μm (C), 200 μm (D,E), 500 μm (F). (D-J) anterior to the left. 
 
Figure 2: tbx1 reporter-expressing cells contribute to LPM-derived cardiac lineages. 
(A-C) Maximum intensity projections of wholemount tbx1:EGFP-expressing embryos counterstained for 
anti-EGFP and anti-MHC (A) or anti-Isl1 (B,C) at 26 hpf; lateral views, anterior to the left. (A) tbx1 
reporter-expression can be detected in the MHC-positive linear heart tube and in the MHC-negative 
poles at the cardiac inflow and outflow tracts (arrowheads). tbx1:EGFP also marks the pharyngeal 
arches (pa) and endothelial cells of the cranial vasculature (cv). (B,C) tbx1 reporter-expressing cells at 
the inflow tract co-express the SHF marker Isl1 (asterisks C); (C) depicts a 3x magnification of the 
framed area in (B). (D) Lineage tracing of tbx1 and drl reporter-expressing cells. tbx1:creERT2 or 
drl:creERT2 transgenics, respectively, were crossed to the ubiquitous hsp70l:Switch loxP tracer line, 4-
OHT-induced at 90% epiboly, and heat-shocked at 3 dpf. (E-G) Live SPIM imaging of still hearts of 
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representative lineage-traced and control embryos; maximum intensity projections of ventral views, 
anterior to the top. (E) tbx1:creERT2 lineage tracing (tbx1>EGFP) at late gastrulation labels 
myl7:DsRed2-expressing cardiomyocytes in the ventricle (V) and inflow tract of the atrium (A), and DAR-
4M-stained cells in the BA (arrowheads). (F) drl:creERT2-mediated lineage tracing (drl>EGFP) at 90% 
epiboly marks all cardiomyocytes in the ventricle and atrium, BA cells (arrowheads), and the 
endocardium (arrows). (G) tbx1:creERT2;hsp70l:Switch transgenics without 4-OHT treatment and heat-
shocked at 3 dpf show no specific EGFP expression (asterisks marks auto-fluorescent pigment cell). 
Scale bars 100 μm. 
 
Figure 3: A tbx1 reporter-expressing sheath forms at the base of the FHF-derived heart tube. 
(A-C) Maximum intensity projections of representative stages from SPIM-imaged tbx1:EGFP;drl:mCherry 
double-positive transgenic embryos; dorsal views, anterior to the top. Imaging was initiated at 14 ss (16 
hpf) and cardiac development followed until LHT stage (22-23 hpf). (A) 14 ss stage embryo at onset of 
medial FHF migration (asterisk). (B) The forming cardiac disc already contains tbx1:EGFP-positive cells 
(arrowhead). (C,D) tbx1:EGFP-positive cells (arrowhead) assemble at the base of the extending drl 
reporter-expressing heart cone (asterisk in C) and are contained in the LHT (arrowhead in D), note 
absence of tbx1:EGFP reporter-expressing cells at the leading edge (asterisk in D) of the forming heart 
tube. (E) 3D segmentation (dorsal and ventral view) revealing a tbx1 reporter-expressing sheath of cells 
engulfing the drl reporter-expressing endocardium at 22-23 hpf. (F) Schematic of tbx1 and drl reporter-
expressing cell arrangements at the end of imaging. Scale bars 50 µm (E), 200 µm (A-D). 
 
Figure 4: tbx1 reporter-expressing SHF-derived myocardial precursors are connected to the FHF 
myocardium during heart tube stages.  
(A-C) Maximum intensity projections of representative stages of a high-resolution reconstruction of the 
beating heart of a tbx1:EGFP;myl7:DsRed2 double positive transgenic between 28-52 hpf; lateral view 
(right side) of the embryo, anterior to the top, ventricle to the upper left, atrium to the lower right, cardiac 
imaging phase 27. Arrows indicate tbx1+/myl7- cells at the OFT and IFT at the beginning of the time-
lapse (A) that gradually turn on myl7 expression (B,C). The dashed line (B,C) indicates the distal end of 
the ventricle and the arrowheads point to tbx1:EGFP-expressing cells at the OFT that never cross into 
the ventricle and are likely BA precursors. (D,E) Maximum intensity projections of SPIM-imaged 
tbx1:EGFP;myl7:DsRed2 double-positive transgenic hearts stopped from contracting with BDM at 54 hpf 
or 3.5 dpf, respectively; ventral views, anterior to the top. tbx1 reporter expression can be detected in 
differentiated tbx1/myl7 reporter double-positive cardiomyocytes (arrows D,E), the tbx1+/myl7- OFT at 54 
hpf (arrowhead D), and the tbx1+/myl7- BA at 3.5 dpf (asterisk E). (F-J) Top-down 2-µm confocal section 
of isolated zebrafish hearts at 26 (F), 54 (G, H) and 72 hpf (I, J) from tbx1:EGFP, counter-stained with 
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anti-GFP and anti-MHC; OFT/BA to the right, atrium (A) to the top left, ventricle (V) to bottom left. (F) 
tbx1:EGFP is expressed at the MHC-negative arterial pole of the heart tube (arrowhead). (G,H) At 54 
hpf, cardiomyocytes of the later-differentiated distal ventricle express tbx1:EGFP (arrowhead), as do 
MHC-negative progenitors of the OFT (asterisks). (I,J) The differentiated BA at 3 dpf is positive for 
tbx1:EGFP. Scale bars 10 µm (F-J), 200 µm (D,E). 
 
Figure 5: The tbx1 reporter-expressing cone forms ventricular myocardium but not the smooth 
muscle-containing outflow tract.  
(A,C,E) Maximum intensity projections and schematics of representative photoconverted tbx1:Dendra2 
embryos; dorsal views, anterior to the top. At 22 hpf, tbx1:Dendra2-expressing embryos were illuminated 
with UV light in a confined region of interest to convert Dendra2-green to Dendra2-red in specific tbx1 
reporter-expressing domains. (B,D,F) SPIM-imaged hearts and graphical representations of embryos 
photoconverted as in A,C,E and stopped from contracting with BDM at 3.5 dpf; maximum intensity 
projections (B,F) or optical Z-section (D), ventral views, anterior to the top. (A,B) Dendra2-red-positive 
sheath cells give rise to ventricular cardiomyocytes, including the SHF-derived distal ventricle, but not to 
the BA. Red signal within the BA (asterisks) derive from autofluorescent blood also detected in non -
photoconverted tbx1:Dendra2 embryos (Figure S6). (C,D) Medial migrating cells posterior to the cardiac 
cone contribute to the most distal myocardium at the dorsal side of the heart (arrowhead) and to a proximal 
portion of the BA in 3/3 analyzed embryos. (E,F) Photoconversion of a broad area in the tbx1:Dendra2-
positive pharyngeal ALPM posterior to and on the right of the linear heart tube marks the right side of the 
BA (dotted outline). Red signals in the chambers, on the pericardium and within cranial vessels are due 
to unspecific autofluorescence also detected in controls (Supplementary Figure 6). Scale bars 50 µm. 
 
Figure 6: fgf8a knock-down leads to perturbed ventricle and BA formation.  
(A-D) Top-down 7 μm confocal section of uninjected control (A,B) and fgf8aATG morphant (C,D) hearts at 3 
dpf. tbx1:EGFP, counter-stained with anti-GFP labels the bulbus arteriosus (BA) (B inset of A’; D inset of 
C’) and scattered ventricular (V) and atrial (A) cardiomyocytes, counter-stained with anti-MHC. (E) 
Quantification of the area of the ventricle in control hearts (n=11) compared to fgf8aATG morphant hearts 
(n=9) reveals significantly smaller ventricle upon knockdown of fgf8a. Each data point stands for the 
averaged ventricular area from one heart. (F) Quantification of the area of the BA in uninjected control 
hearts (n=10) compared to fgf8aATG morphant hearts (n=9) displays significantly smaller BA in the loss of 
fgf8a. Each data point represents the measurement of the BA area from one heart. (G,H) Top-down 3 μm 
confocal section of uninjected control (G) and fgf8aATG morphant (H) hearts at 54 hpf. drl:EGFP, counter-
stained with anti-GFP labels FHF-derived cardiomyocytes marked by anti-MHC. (I) The ratio between the 
area of drl:EGFP positive cells and the area of the entire ventricle is not significantly different comparing 
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controls and fgf8aATG morphants (P=0.133). Each data point presents calculated ratio from one heart. 
Means±s.d.. ****P<0.0001, unpaired t-test with Welch correction. Scale bars 10 µm. 
 
Figure 7: FGF signaling differentially affects tbx1 reporter-expressing ventricular and bulbus 
arteriosus precursors during heart tube formation.  
(A,B) Maximum intensity projections of representative tbx1:EGFP;drl:mCherry transgenic controls or 
embryos treated with 5 µM SU5402 from 14 ss to 22 hpf; lateral/dorsal view, anterior to the left. FGF-
signaling perturbed embryos show a defect in the tbx1:EGFP-expressing sheath (arrowhead) at the base 
of the forming heart tube (outline). (C-E) FGF-perturbed embryos retain normal contribution of 
tbx1:EGFP-expressing cardiomyocytes to the ventricle upon pulsed or continuous signaling inhibition; 
ventral views, anterior to the top. Instead, FGF signaling perturbation leads to a diminished ventricle size 
and abolishes addition of the tbx1 reporter-expressing BA to the heart (asterisks). (F-I) SU5402 
treatments affect BA development in a time- and concentration-dependent manner; n indicates the 
number of individual embryos analyzed per condition, N indicates the number of individual experiments 
performed. (F) Quantification of the concentration-dependent effect on BA formation in FGF signaling 
perturbed tbx1:EGFP;myl7:Red or DAR-4M-stained myl7:EGFP transgenics (see additionally Figure S7). 
(G-I) tbx1:EGFP;myl7:DsRed transgenic controls and embryos treated with DMSO or 5 µM SU5402 
during (14 ss – 22hpf) or after (24 hpf – 28 hpf) heart tube formation; lateral views, anterior to the left. 
Absent BA formation can only be observed in embryos treated with SU5402 from mid-somitogenesis to 
heart tube stages (arrow head H), but not when signaling inhibition is initiated at 24 hpf (arrow head I). 
Scale bars 50 µm (C-E), 100 µm (A,B, G-J). 
 
 
  
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/230649doi: bioRxiv preprint first posted online Dec. 7, 2017; 
24 
 
Supplementary Material  
 
Supplementary Table 1: Comparison of tbx1:EGFP-transgenic zebrafish lines.  
Comparison of fluorescence intensity, the number of transgenic insertions and unspecific signals in F1 
tbx1:EGFP line I-VI transgenics. Lines I (Tg(-3.2tbx1:EGFP_I)zh702), IV, and V were retained and all 
experiments performed in F2 generations or beyond of line I, and some experimental outcomes confirmed in 
the other retained lines. 
 
Supplementary Figure 1: tbx1 reporter- and endogenous expression in different transgenic lines and 
at different timepoints.  
(A,B) Anterior expression in different transgenic tbx1:EGFP lines at 20 ss (A) and 24-28 hpf (B); lateral 
views, anterior to the left. Expression in all lines is confined to the anterior CPF with some minor unspecific 
signals in the notochord or scattered posterior skeletal muscles (see Table S1). (C) Cardiac tbx1:EGFP 
expression in all lines is strongest in the ventricle and outflow tract at 60 hpf; lateral view of the right side of 
the embryo due to better visibility of the outflow tract, anterior to the right. (D,E) Endogenous tbx1 
expression confines to a dorsal domain during gastrulation; (D) animal view, (E) lateral view; V: ventral, D: 
dorsal, A: animal, Veg: vegetal. (F-H) By mRNA ISH, tbx1:EGFP and tbx1 expression is detected in anterior 
pharyngeal precursors from mid-somitogenesis to heart tube stages (16 ss to 30 hpf). Additionally, tbx1 
reporter expression marks the migrating heart field at the midline (asterisk) and emerging fin bud precursors 
(arrowheads); dorsal views, anterior to the top. (I) tbx1:EGFP and tbx1 are confined to anterior domains 
with no expression in posterior structures; asterisks heart tube in tbx1:EGFP, arrowhead fin bud 
precursors; lateral views, anterior to the left. Scale bars 100 µm (F-H), 250 µm (A,C), 500 µm (B,I). 
 
Supplementary Figure 2: Transverse sections of tbx1 reporter expression and CreERT2/lox-mediated 
tbx1 lineage tracing.  
(A-L) Transverse agarose sections of 3 dpf transgenic or control embryos aligned top to bottom from 
anterior to posterior with endogenous EGFP reporter fluorescence (green) and nuclear stain (DAPI, blue); 
top-down confocal Z-sections; dorsal to the top. (A) In the anterior-most sections, tbx1:EGFP reporter 
expression is confined to neural crest-derived mandibular cartilage (m) and ALPM-derived cranial 
vasculature (cv). (B,C) Further posterior branchial arches (ba, containing mesodermal, endodermal and 
neural crest lineages) and the endodermal pharynx (ph) express tbx1:EGFP. (D,E) tbx1:EGFP reporter 
expression can be also found in the endodermally derived swim bladder (sb) and in the anterior gut (ag), 
and weakly in the liver (l) but not in the posterior gut segments (pg) at the height of the swim bladder, 
suggesting absence of tbx1 reporter activity in more posterior segments. (F) No organ-specific EGFP signal 
can be observed in non-transgenic (wildtype, wt) controls, but autofluorescent signal in the skin and blood 
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can be observed in controls and throughout all sections (asterisk A-L). (G-K) Akin to tbx1:EGFP reporter 
expression, tbx1:creERT2-mediated lineage tracing throughout gastrulation (shield-bud, tbx1>EGFP) marks 
the branchial arches (ba), pharynx (ph), anterior gut (ag), liver (l), and swim bladder (sb). As observed by 
live imaging of lineage-traced embryos (Figure 2), ventricular myocardium of the heart (h) is also marked. 
The posterior gut was only labelled in 2/7 embryos, supporting loss of enhancer activity in more posterior 
endodermal precursors. (L) No unspecific switching activity was observed in heat shock (hs) controls. Scale 
bars 500 µm. 
 
Supplementary Figure 3: Tissue-specific tbx1 reporter expression and lineage tracing in 
cardiopharyngeal tissues.  
(A) Maximum intensity projections of fixed whole-mount immunofluorescence from 60 hpf tbx1:EGFP 
embryos counterstained with anti-EGFP and anti-MHC; ventral view, anterior to the top. tbx1:EGFP-positive 
cranio-branchial derivatives observed through lineage tracing and reporter expression in previous 
experiments include the cranial muscles inferior oblique (io) and adductor mandibulae (am). (B) 
tbx1:creERT2 transgenics were crossed to ubi:Switch and induced with 4-OHT at the end of gastrulation 
(90% epiboly). ubi:Switch (ubi:loxP-EGFP-loxP-mCherry) switches from EGFP to mCherry expression in all 
cells expressing the creERT2 transgene at the time of 4-OHT induction. (C) mCherry-expressing 
tbx1:creERT2 derivatives (tbx1>mCherry) at 4.5 dpf can be found in the heart (h), cranio-branchial 
derivatives (cbd), mandibular cartilage (m), and in the ear (ea). The inlet in (C’’) depicts the brightfield image 
of (C-C’’); lateral view, anterior to the left. (D) tbx1:creERT2 or drl:creERT2 transgenics, respectively, were 
crossed to the ubiquitous hsp70l:Switch loxP tracer line, 4-OHT-induced at shied stage or 90% epiboly, 
and heat-shocked at 3 dpf. (E,F) Maximum intensity projections from SPIM-imaged 3.5 dpf embryo; ventral 
views, anterior to the top. (D) tbx1:creERT2;hsp70l:Switch double-transgenic embryos were induced with 4-
OHT at shield stage to capture the earliest derivatives of tbx1 reporter-expressing progenitors. tbx1 lineage-
traced cells (tbx1>EGFP) are located in ventricular (V) myocardium, atrial (A) myocardium at the inflow tract, 
and in the DAR-4M-marked bulbus arteriosus (BA). Additionally, cranio-branchial derivatives (cbd) and 
cranial vessels (cv) are readily marked by tbx1 lineage tracing. (B) drl:creERT2-mediated lineage tracing 
(drl>EGFP) was initiated at 90% epiboly to label LPM derivatives that can be found in all cardiac structures 
(V, A, BA) and cranial vasculature (cv). Scale bars 100 µm (A,E,F), 250 µm (C). 
 
Supplementary Figure 4: tbx1 reporter-expression at the base of the linear heart tube and smooth 
muscle of the BA.  
(A-C) Maximum intensity projections of representative stages from SPIM-imaged 
tbx1:EGFP;myl7:DsRed2 double transgenic embryos, dorsal views, anterior to the top. Imaging was 
initiated at 18 hpf and heart development was followed up to 30 hpf. tbx1:EGFP-only cells were observed 
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at the base of the myl7:DsRed2-positive linear heart tube at all stages imaged (arrow heads). Imaging 
was performed on tbx1:EGFP line IV embryos; note the strong notochord expression (asterisk) not 
observed in line I (see also Figure S1 and Table S1). (D,E) Transverse agarose sections of 
tbx1:EGFP;drl:mCherry (D) or drl:mCherry (E) transgenic embryos with endogenous EGFP (green) and 
mCherry (magenta) reporter fluorescence and nuclear stain (DAPI, blue); top-down confocal z-sections; 
dorsal to the top. drl:mCherry is expressed in endothelial cells (ec) and blood (b), tbx1:EGFP is specific to 
the smooth muscle layer of the bulbus arteriosus (sm). tbx1 reporter expression can be also detected in 
the myocardium of the inner curvature (cm) and in the branchial arches (ba).  Scale bars 50 µm. 
 
Supplementary Figure 5: Myocardium in all ventricular segments derives from the tbx1:Dendra2-
expressing sheath at the base of the forming heart tube.  
(A-C) Maximum intensity projections of the heart shown in Figure 5B with myl7:AmCyan demonstrating that 
photoconverted cells from the tbx1 reporter-expressing sheath at the base of the forming heart tube at 22 
hpf contribute to ventricular myocardium at 3.5 dpf; ventral view, anterior to the top. (D) A second 
representative tbx1:Dendra2 embryo converted at the base of the forming heart tube at 22 hpf is shown; 
maximum intensity projection, dorsal view, anterior to the top. (E-H) Live SPIM-imaging of the same embryo 
depicted in (D) at 3.5 dpf; ventral view, anterior to the top. Optical z-sections from ventral (E), medial (F) and 
dorsal (G) regions as well as the maximum intensity projection (H) show that regions of the ventricular 
myocardium, including most distal segments, but not the bulbus arteriosus, are contributed from the 
photoconverted sheath at 22 hpf. Dendra2-red in all or only the distal-most ventricular myocardium (as 
depicted in A-C) was observed in 10/11 embryos with tbx1 reporter-expressing sheath conversion at 22 hpf. 
In 1/11 embryos, no Dendra2-red cells could be found in the entire anterior region of the embryo. Scale bars 
50 µm.  
 
Supplementary Figure 6: Different regions of the pharyngeal LPM contribute to distinct parts of the 
BA and craniofacial structures.  
(A-D) Maximum intensity projections and schematics of representative photoconverted tbx1:Dendra2 
embryos; dorsal views, anterior to the top. At 22 hpf, tbx1:Dendra2-expressing embryos were illuminated 
with UV light in a confined region of interest to convert Dendra2-green to Dendra2-red in specific tbx1 
reporter-expressing domains. (E-H) Maximum intensity projections and graphical representations of hearts 
of tbx1:Dendra2 embryos photoconverted in (A-D) at 3.5 dpf with marked contribution to the heart by 
photoconverted cells; ventral views, anterior to the top. (A,E) Photoconversion of a broad area in the 
tbx1:Dendra2-positive pharyngeal LPM posterior to and on the left of the cardiac cone marks the left side 
of the BA (dotted outline). (B,F) The most medial region of the area converted in (A) contributes to the 
most proximal part of the BA suggesting that these progenitors migrate and add the earliest to the heart. 
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(C,G) A lateral and anterior region to (B) contributes to the medial part of the BA. (D,H) The most 
posterior and lateral region makes the distal part of the BA and contributes to cells of the ascending 
aorta. (I-K) Maximum intensity projections of photoconverted tbx1:Dendra2 embryos at 3.5 dpf; ventral 
views, anterior to the top. Photoconverted regions as in (B-D), (J) and (K) depict the same embryos as 
shown in (C) and (D), respectively; (I) shows an embryo that was photoconverted in an equivalent but 
right-hand sided region as shown in (B). Progenitors of different parts of the BA derive from the same 
areas as different parts of craniofacial muscles and cartilage. (L) Maximum intensity projections of an 
unconverted tbx1:Dendra2 embryo; ventral view, anterior to the top. Red signal from blood (asterisks) and 
on top of the pericardium (arrows) were observed in unconverted Dendra2 embryos imaged at 3.5 dpf using 
lightsheet microscopy, suggesting unspecific auto-fluorescence in these structures picked up at the imaging 
conditions used for Dendra2 experiments. Scale bars 50 µm. 
 
Supplementary Figure 7: Aberrant formation of the DAR-4M-stained BA upon FGF signaling 
perturbation.  
(A-D) myl7:EGFP, DAR-4M-stained embryos treated with DMSO or 5µM SU5402 during (14 ss- 22hpf) or 
after (24 hpf-34 hpf) heart tube formation; lateral views, anterior to the left. Absent BA formation can only 
be observed in embryos treated with SU5402 from mid-somitogenesis to heart tube stages (arrow head 
B), but not when signaling inhibition is initiated at 24 hpf (arrow head D). Scale bars 100 µm.  
 
Supplementary Video 1: Panoramic lightsheet-imaging of the early development of a 
tbx1:EGFP;drl:mCherry embryo.  
Mercator projection of early developmental stages from 8 -15 hpf, tbx1:EGFP is depicted in green, 
drl:mCherry in magenta, dorsal view, anterior to the left. Movie stacks were acquired every 2 min. Frame 
rate of the movie: 29 frames per second (fps). 1 sec in the movie corresponds approximately to 30 min in 
development. 
 
Supplementary Video 2: Lightsheet imaging of the cardiopharyngeal field of a 
tbx1:EGFP;drl:mCherry embryo.  
Maximum intensity projection with the dorsal view of the anterior region of a tbx1:EGFP;drl:mCherry 
transgenic, anterior to the top right corner; tbx1:EGFP depicted in green, drl:mCherry in magenta. Cardiac 
development was followed from 14 ss to 23 hpf. Movie stacks were acquired approximately every 7.5 min. 
Frame rates 7 fps. 1 sec in the movie corresponds approximately to 52.5 min in development. 
 
Supplementary Video 3: Animated 3D segmentation of the tbx1 reporter-expressing sheath at the 
base of the heart tube. Rotation of the 3D segmentation of still from Video S2 shown in Figure 3D 
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revealing a tbx1 reporter-expressing sheath of cells at the base of the forming heart tube and engulfing 
the drl reporter-expressing endocardium at 22-23 hpf. 
 
Supplementary Video 4: Lightsheet-imaging of the developing heart tube of a 
tbx1:EGFP;myl7:DsRed2 embryo.  
Maximum intensity projection with the dorsal view of the anterior region of a tbx1:EGFP;myl7:DsRed2 
transgenic, anterior to the top; tbx1:EGFP depicted in green, myl7:DsRed2 in magenta. Heart tube 
development was followed from 18 ss to 30 hpf. Movie stacks were acquired approximately every 2.8 min. 
Frame rates 10 fps. 1 sec in the movie corresponds approximately to 28 min in development. 
 
Supplementary Video 5: Time-lapse of a high-speed SPIM-imaged beating heart in a 
tbx1:EGFP;myl7:DsRed2 transgenic.  
Heart development was followed from 28-52 hpf, all time points are synchronized and shown at contraction 
phase 27, heart imaged from right side of the embryo, lateral view, anterior to the top, ventricle to the 
upper left, atrium to the lower right. tbx1:EGFP is depicted in cyan, myl7:DsRed2 in red. Frame rates 7 fps. 
1 sec in the movie corresponds approximately to 144 min in development. 
 
Supplementary Video 6: tbx1:EGFP-expression in a beating heart at 28 hpf reconstructed from high-
speed SPIM-imaging.  
Volume rendering showing a cardiac cycle in slow motion in a 28 hpf embryo heart as imaged in Video S5. 
Only EGFP expression is shown to highlight that all tbx1 reporter-expressing cardiac cells move during 
cardiac contraction.  
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Methods 
 
Animal husbandry  
 Zebrafish (Danio rerio) were maintained, collected, and staged principally as described (Kimmel et al., 
1995; Westerfield, 2007) and in agreement with procedures mandated by the veterinary office of UZH and 
the Canton of Zürich. Embryos were raised in temperature-controlled incubators without light cycle at 28°C 
unless specified differently in the text. 
 
Vectors and transgenic lines 
All transgenic lines newly generated in this work have been assigned unique ZFIN designations. The 
upstream cis-regulatory region of the zebrafish tbx1 gene (ZDB-GENE-030805-5) was amplified from 
zebrafish wildtype genomic DNA with primers 5’-GCTTATACGCACGACTGC-3’ (forward) and 5’-
TGTGTCGATCGCGTATCGC-3’ (reverse) with the Expand Hi-Fidelity PCR kit (Roche). The 3242 bp 
upstream region of tbx1 was TOPO-cloned into the pENTR™ 5'-TOPO® TA Cloning® plasmid (Cat#59120; 
Invitrogen) according to manufacturer’s instructions to obtain pAF006 (pENTR/5’_tbx1). 
Subsequent cloning reactions were performed with the Multisite Gateway system with LR Clonase II Plus 
(Cat#12538120; Life Technologies) according to the manufacturer’s instructions. 
 tbx1:EGFP (pAF008 or pDestTol2pA2_tbx1:EGFP) and tbx1:H2B-Dendra2 (pAF048 or 
pDestTol2pA2_tbx1:H2B-Dendra2) were assembled from pAF006 together with Tol2kit #383 (pME-EGFP) 
or pKP003 (pME-H2B-Dendra2), #302 (p3E_SV40polyA), and #394 (pDestTol2A2) as backbone (Kwan et 
al., 2007). This vector was used to generate transgenic strain Tg(-3.2tbx1:EGFP)zh702 based in founder line 
I, and the additional lines for comparison as depicted in Figure S1 to ensure faithful transgene expression. 
 We cloned tbx1:creERT2 (pAF038 or pDestTol2CY_tbx1:creERT2,alpha-crystallin:Venus) by combining 
pAF006 with pCM293 (pENTR/D_creERT2) (Mosimann et al., 2011), Tol2kit vector #302 (Kwan et al., 
2007), and pCM326 (pDestTol2CY, containing the alpha-crystallin:Venus cassette as transgenesis marker) 
as backbone(Mosimann et al., 2015). This vector was used to generate transgenic strain Tg(-
3.2tbx1:creERT2; cryaa:Venus)zh703, which we selected as best line after screening several transmitting 
founders. 
 The hsp70l:Switch (pAF040 or pDestTol2CY_hsp70l:loxP-STOP-loxP-EGFP,alpha-crystallin:Venus) 
transgene was assembled from pDH083 (Hesselson et al., 2009) by transfer of the loxP cassette into 
pENTR5’ (generating pENTR/5’_hsp70l:loxP-STOP-loxP), Tol2kit #383 and #302(Kwan et al., 2007), and 
pCM326 as backbone. This vector was used to generate transgenic strain Tg(-1.5hsp70l:loxP-STOP-loxP-
EGFP,cryaa:Venus)zh703. 
 For Tol2-mediated zebrafish transgenesis, 25 ng/µL Tol2 mRNA were injected with 25 ng/µL plasmid DNA 
(Felker and Mosimann, 2016; Kwan et al., 2007). F0 founders were screened for specific EGFP or alpha-
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crystallin:YFP expression, raised to adulthood, and screened for germline transmission. Single-insertion 
transgenic strains were established and verified through screening for a 50% germline transmission rate in 
outcrosses in the subsequent generations as per our previously outlined procedures (Felker and Mosimann, 
2016).  
 Additional already established transgenic lines used in this study included drl:mCherry (Tg(-
6.3drl:mCherry)zh705), myl7:DsRed2 (Chiavacci et al., 2012), ubi:Switch (Mosimann et al., 2011), and 
drl:creERT2 (Mosimann et al., 2015). 
 
Morpholino injections 
 The fgf8aATG morpholino (MO3-fgf8aATG: 5'-GAGTCTCATGTTTATAGCCTCAGTA-3'; ZFIN ID: ZDB-
MRPHLNO-050714-1) that blocks translation (Scholpp and Brand, 2001) was obtained by Gene Tools, LLC 
and injected in the yolk of one- to four cell-stage embryos. 
 
Agarose sections 
 Transverse sections of agarose embedded embryos at 3 dpf were made as previously described (Gays et 
al., 2017). Briefly, embryos were fixed in 4% PFA, embedded in 6% low-melting point agarose (Sigma), cut 
into 130 mm vibratome sections (VT1000S, Leica), and mounted with DAPI-containing Vectashield (Cat#H-
1200; Vector Laboratories). 
 
Whole-mount in situ hybridization 
 First-strand complementary DNA (cDNA) was generated from wildtype zebrafish RNA isolated with 
Superscript III First-Strand Synthesis kit (Cat#18080051; Invitrogen). DNA templates were generated using 
first-strand cDNA as PCR template and following primers: EGFP with 5’-
ATGGTGAGCAAGGGCGAGGAGC-3’ (forward) and 5’-TAATACGACTCACTATAGGG -3’ (reverse); tbx1 
with 5’-TATTCCGGATCCAACTCAGC-3’ (forward) and 5’-TTATCTGGGTCCGTAGTC-3’ (reverse). For in 
vitro transcription, the T7 RNA polymerase promoter 5'-TAATACGACTCACTATAGGG-3’ was added to the 
5’-end of reverse primers. In situ hybridization probes were made by in vitro transcription using T7 RNA 
polymerase and DIG-labeled NTPs (Cat#11277073910; Roche). RNA was precipitated with lithium chloride 
in ethanol and dissolved in DEPC water. Embryos were fixed in 4% Paraformaldehyde (PFA) overnight at 
4°C, transferred into 100% methanol, and stored at -20°C until in situ hybridization. In situ hybridization of 
whole-mount zebrafish embryos was performed according to published protocols (Thisse and Thisse, 2008). 
 
Antibody staining 
 Embryos were fixed in 4% Formaldehyde, 0.1% TritonX in PEM (0.1 M PIPES, 2 mM MgSO4, 1 mM 
EDTA) for 2-4h at room temperature, washed in 0.1% PBS TritonX (PBSTx) and permeabilized in 0.5% 
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PBSTx. Hearts from 26, 54 and 72 hpf zebrafish embryos were dissected in Tyrode’s solution (136 mM 
NaCl, 5.4 mM KCl, 1 mM MgCl2 x 6H2O, 5 mM D(+)Glucose, 10 mM HEPES, 0.3 mM Na2HPO4 x 2 H2O, 1.8 
mM CaCl2 x 2H2O; pH 7.4) with 20 mg/mL BSA and fixed with Shandon™ Glyo-Fixx™ (Cat#9990920; 
Thermo Fisher Scientific™) for 20 min at room temperature. Blocking was done in blocking buffer containing 
5% goat serum, 5% BSA, 20 mM MgCl2 in PBS and embryos/hearts incubated with primary antibodies 
diluted in blocking buffer at 4°C overnight. Primary antibodies used were anti-MHC (MF20 Supernatant, 
DSHB, 1:50), anti-GFP (Abcam, ab13970, 1:500 or Sigma, G1544, 1:100), and anti-Isl1 (GeneTex, 
GTX128201, 1:50). Alexa-conjugated secondary antibodies (A11039, A11004, A11008, and A11012 
ThermoFisher Scientific) were added at 1:500 in 0.1% PBSTx at 4°C overnight. Embryos were washed 
several times in 0.1% PBSTx. DAPI-containing Vectashield (Cat#H-1200; Vector Laboratories) was added 
and embryos kept in the mounting medium until imaging. Before imaging, embryos were mounted in 1% 
low-melting point agarose. Dissected hearts were washed overnight in blocking buffer and mounted in the 
ProLong Gold antifade reagent with DAPI (Cat#P36935; ThermoFisher Scientific™).  
 
CreERT2-based lineage tracing 
 Lineage tracing experiments were performed by crossing female hsp70l:Switch or ubi:Switch reporter 
carriers with male creERT2 driver transgenics (Felker and Mosimann, 2016). Embryos were induced using 
4-OHT (Cat#H7904: Sigma) from fresh and/or pre-heated (65°C for 10 minutes) stock solutions in DMSO 
with a final concentration of 10 μM in E3 embryo medium as per our established protocols (Felker et al., 
2016). Heat-shocks were performed for 60 min at 37°C in glass tubes in a water bath.  
 
Microscopy and image analysis 
 Stereo microscopy images were obtained on a Leica M205FA equipped with a Leica DFC450C digital 
camera. Confocal images of transverse sections were obtained on an inverted Zeiss LSM710 confocal 
microscope with a Plan-Apochromat 40x/1.3 Oil DIC M27 objective. Confocal imaging of whole-mounts and 
dissected hearts was done with a Leica SP8 upright confocal microscope using a HC PL APO 20x/0.5 
Water objective and Leica SP8 inverted confocal microscope using a HC PL APO CS2 63x glycerol/NA 1.3 
objective, respectively. 
SPIM/lightsheet microscopy was performed on a Zeiss Z.1. Embryos were embedded in 1% low-melting 
point agarose and 0.016% Ethyl 3-aminobenzoate methanesulfonate salt (Tricaine, Cat#A5040; Sigma) in 
E3 embryo medium in a 50 µL glass capillary. Heart beat was stopped with 30 mM 2,3-Butanedione 
monoxime (BDM, Cat#B0753; Sigma) as indicated in individual experiments.  
 Dendra2 photoconversion experiments were performed on an inverted Zeiss LSM710 confocal microscope 
with the Plan-Apochromat 20x/0.8 M27 or LD LCI Plan-Apochromat 25x/0.8 Imm Korr DIC M27 objectives. 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/230649doi: bioRxiv preprint first posted online Dec. 7, 2017; 
32 
 
Embryos were embedded in 1% low-melting point agarose and 0.016% Tricaine in E3 embryo medium in 
glass-bottom plates orienting the anterior dorsal side of the embryo towards the bottom of the plate. 
 Panoramic SPIM and high-resolution SPIM of the beating zebrafish heart as well as image processing 
(Mercator projections and reconstruction of the beating heart) were performed essentially as described 
(Mickoleit et al., 2014; Schmid et al., 2013). 
Images were processed using Leica LAS, ImageJ/Fiji, Imaris, and Photoshop CS6. The area of the BA, 
ventricle and regions positive for drl:EGFP were measured from confocal image Z-projections of dissected 
hearts using ImageJ/Fiji. Extracted data were processed with GraphPad Prism 7 using unpaired t-test with 
Welch correction, reported P values are two-tailed. 
 
Chemical treatments 
 SU5402 (Sigma) was administered to embryos at concentrations ranging from 2-5 µM in E3 at desired 
stages and for specific periods of time as indicated in the text. The drug was washed out through several 
washing steps with E3. Diaminorhodamine-4M AM solution (DAR-4M, Cat#D9194; Sigma) was diluted 
1:1000 in E3 containing 0.003% 1-phenyl-2-thiourea (PTU, Cat#P7629; Sigma) and live embryos incubated 
in the staining solution for at least 48h at 28°C. DAR-4M was washed out through several washing steps 
before imaging. Controls were treated with equivalent amounts of DMSO. 
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